Your browser doesn't support javascript.
loading
First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial.
Verdijk, Pauline; van der Plas, Johan L; van Brummelen, Emilie M J; Jeeninga, Rienk E; de Haan, Cornelis A M; Roestenberg, Meta; Burggraaf, Jacobus; Kamerling, Ingrid M C.
Afiliación
  • Verdijk P; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands.
  • van der Plas JL; Centre for Human Drug Research, Leiden, The Netherlands; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • van Brummelen EMJ; Centre for Human Drug Research, Leiden, The Netherlands.
  • Jeeninga RE; Viroclinics Biosciences B.V., Rotterdam, The Netherlands.
  • de Haan CAM; Virology Division, Department Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
  • Roestenberg M; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.
  • Burggraaf J; Centre for Human Drug Research, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands.
  • Kamerling IMC; Centre for Human Drug Research, Leiden, The Netherlands; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: IdVisser@chdr.nl.
Vaccine ; 38(39): 6088-6095, 2020 09 03.
Article en En | MEDLINE | ID: mdl-32718816

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio Tipo de estudio: Clinical_trials Límite: Adult / Aged / Animals / Child / Child, preschool / Humans Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio Tipo de estudio: Clinical_trials Límite: Adult / Aged / Animals / Child / Child, preschool / Humans Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos